Patent No. US 7,157,493 B2: A method of reducing low density lipoprotein while not significantly reducing high density lipoprotein using a theaflavin, theaflavin-3-gallate, theaflavin-3’-gallate and theaflavin 3,3’-digallate has been patented by Nashai Biotech, LLC, Nashville, TN.
The latest exclusive market research from Smithers Pira projects positive growth for the across the nonwoven wipes industry. This market can be subdivided into two major types:
Consumer wipes include b…